These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 33355202)
21. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964 [TBL] [Abstract][Full Text] [Related]
22. USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy. Wang SA; Young MJ; Jeng WY; Liu CY; Hung JJ Sci Rep; 2020 Nov; 10(1):20870. PubMed ID: 33257797 [TBL] [Abstract][Full Text] [Related]
23. The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation. Holland AJ; Cleveland DW J Clin Invest; 2012 Dec; 122(12):4325-8. PubMed ID: 23187131 [TBL] [Abstract][Full Text] [Related]
24. MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer. Sun Y; Ji P; Chen T; Zhou X; Yang D; Guo Y; Liu Y; Hu L; Xia D; Liu Y; Multani AS; Shmulevich I; Kucherlapati R; Kopetz S; Sood AK; Hamilton SR; Sun B; Zhang W J Pathol; 2017 Jan; 241(1):67-79. PubMed ID: 27741356 [TBL] [Abstract][Full Text] [Related]
25. Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma. Kuick CH; Tan JY; Jasmine D; Sumanty T; Ng AYJ; Venkatesh B; Chen H; Loh E; Jain S; Seow WY; Ng EHQ; Lian DWQ; Soh SY; Chang KTE; Chen ZX; Loh AHP BMC Cancer; 2022 Jun; 22(1):717. PubMed ID: 35768791 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605 [TBL] [Abstract][Full Text] [Related]
27. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2. Yang HW; Chen YZ; Takita J; Soeda E; Piao HY; Hayashi Y Oncogene; 2001 Aug; 20(36):5075-83. PubMed ID: 11526494 [TBL] [Abstract][Full Text] [Related]
28. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669 [TBL] [Abstract][Full Text] [Related]
29. Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice. Zhou H; Zhang R; Lu K; Yu W; Xie B; Cui D; Jiang L; Zhang Q; Xu S J Neurol Sci; 2016 Aug; 367():3-10. PubMed ID: 27423553 [TBL] [Abstract][Full Text] [Related]
33. Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis. Yu Y; Chen F; Jin Y; Yang Y; Wang S; Zhang J; Chen C; Zeng Q; Han W; Wang H; Guo Y; Ni X Acta Biochim Pol; 2020 Dec; 67(4):595-603. PubMed ID: 33326736 [TBL] [Abstract][Full Text] [Related]
34. Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma? Tonini GP Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439783 [TBL] [Abstract][Full Text] [Related]
35. Collapsin response mediator protein 2 is involved in regulating breast cancer progression. Shimada K; Ishikawa T; Nakamura F; Shimizu D; Chishima T; Ichikawa Y; Sasaki T; Endo I; Nagashima Y; Goshima Y Breast Cancer; 2014 Nov; 21(6):715-23. PubMed ID: 23381229 [TBL] [Abstract][Full Text] [Related]
36. Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis? Tonini GP BMC Cancer; 2017 Jan; 17(1):20. PubMed ID: 28056863 [TBL] [Abstract][Full Text] [Related]
37. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN. Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116 [TBL] [Abstract][Full Text] [Related]